Adipose Stem Cells from Type 2 Diabetic Mice Exhibit Therapeutic Potential in Wound Healing
May 2020
in “
Research Square (Research Square)
”
New to Vascular Endothelial Growth Factor? There is a guide in the encyclopedia. Read the guide → adipose-derived mesenchymal stem cells ASCs type 2 diabetic mice wound healing hepatocyte growth factor HGF vascular endothelial growth factor VEGF transforming growth factor β TGF-β skin fibroblast proliferation inflammation macrophage infiltration fat-derived stem cells diabetic mice wound repair skin cell growth immune cell infiltration
Studysummary The researchers reported that adipose-derived stem cells from type 2 diabetic mice showed comparable therapeutic effects in wound healing to control cells, despite slightly reduced growth factor secretion and healing promotion.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Adipose-derived mesenchymal stem cells (ASCs) from type 2 diabetic (T2D) mice were found to be slightly less effective in promoting wound healing compared to control ASCs, as they secreted lower levels of hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), and transforming growth factor β (TGF-β). Despite this, T2D ASCs still exhibited comparable therapeutic effects in wound healing, promoting skin fibroblast proliferation and migration, and suppressing inflammation and macrophage infiltration. The study concluded that ASCs from T2D mice, while marginally inferior, still held significant potential for therapeutic use in wound healing.
